Table 1 Clinico-pathologic features of the Hodgkin lymphoma patients
From: The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt
Characteristics | Number 81 (%) |
|---|---|
Age (years) | |
Mean ± SD | 40.7 ± 15.5 |
Gender | |
Male | 51 (63%) |
Female | 30 (37%) |
Stage | |
I | 1 (1.23%) |
II | 27 (33.3%) |
III | 39 (48.15%) |
IV | 14 (17.3%) |
Histological subtypes | |
Nodular sclerosis | 45 (55.5%) |
Mixed cellularity | 33 (40.7%) |
Lymphocyte-rich | 2 (2.46%) |
Lymphocyte- depleted | 1 (1.23%) |
B symptoms | |
Negative | 59 (72.8%) |
Positive | 22 (27.1%) |
Bulky disease | |
≥ 10CM | 17 (21%) |
< 10CM | 64 (79%) |
International Prognostic Score (IPS) | |
≥ 4 (high risk) | 19 (23.4%) |
< 4 (low risk) | 62 (76.5%) |
Management | |
Primary treatment ABVD | 81(100) |
IFRT | 8 (9.87%) |
2nd line | 20 (24.6%) |
BMT | 1 (1.2%) |